Your search returned 3 results.

Results
	1.	Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). [electronic resource] by Lam, Carolyn S P McEntegart, Margaret Claggett, Brian Liu, Jiankang Skali, Hicham Lewis, Eldrin Køber, Lars Rouleau, Jean Velazquez, Eric Califf, Rob McMurray, John J Pfeffer, Marc Solomon, Scott Producer: 20160128 In: European journal of heart failure vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). [electronic resource] by McMurray, John Solomon, Scott Pieper, Karen Reed, Shelby Rouleau, Jean Velazquez, Eric White, Harvey Howlett, Jonathan Swedberg, Karl Maggioni, Aldo Køber, Lars Van de Werf, Frans Califf, Rob Pfeffer, Marc Producer: 20060428 In: Journal of the American College of Cardiology vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. [electronic resource] by Simes, R John O'Connell, Rachel L Aylward, Philip E Varshavsky, Sergei Diaz, Rafael Wilcox, Robert G Armstrong, Paul W Granger, Christopher B French, John K Van de Werf, Frans Marschner, Ian C Califf, Rob White, Harvey D Producer: 20100715 In: American heart journal vol. 159 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)